| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Attenuated enterovirus or rhinovirus; poliovirus having attenuating mutation; useful as recombinant vaccine; protein engineering
|
|
|
1991
|
9 |
3 |
p. 213-
1 p.
|
article
|
| 2 |
Babesia DNA, polypeptides and monoclonal antibodies; Babesia bovis antigen gene cloning and expression in Escherichia coli; monoclonal antibody preparation and hybridoma construction; potential recombinant vaccine construction
|
|
|
1991
|
9 |
3 |
p. 213-
1 p.
|
article
|
| 3 |
Calendar
|
|
|
1991
|
9 |
3 |
p. C03-
1 p.
|
article
|
| 4 |
Comparison of cyclodextrin solid medium containing blood with Bordet—Gengou medium for growth of Bordetella pertussis phase I organisms
|
Gupta, R.K.
|
|
1991
|
9 |
3 |
p. 215-216
2 p.
|
article
|
| 5 |
Effect of passive antibody on the immune response of cotton rats to purified F and G glycoproteins of respiratory syncytial virus (RSV)
|
Murphy, Brian R.
|
|
1991
|
9 |
3 |
p. 185-189
5 p.
|
article
|
| 6 |
Efficacy studies on a canarypox-rabies recombinant virus
|
Taylor, Jill
|
|
1991
|
9 |
3 |
p. 190-193
4 p.
|
article
|
| 7 |
Efficacy trial of a parenteral gonococcal pilus vaccine in men
|
Boslego, John W.
|
|
1991
|
9 |
3 |
p. 154-162
9 p.
|
article
|
| 8 |
Hepatitis B virus infection in a successfully immunized patient
|
Levi, Guido Carlos
|
|
1991
|
9 |
3 |
p. 216-
1 p.
|
article
|
| 9 |
Induction of protection level of anti-pre-S2 antibodies in humans immunized with a novel hepatitis B vaccine consisting of M (pre-S2 + S) protein particles (a third generation vaccine)
|
Kuroda, Shun'ichi
|
|
1991
|
9 |
3 |
p. 163-169
7 p.
|
article
|
| 10 |
Keratoconjunctivitis cytotoxin from Moraxella bovis; toxic to cattle peripheral blood neutrophils but lacking haemolytic activity; vaccine
|
|
|
1991
|
9 |
3 |
p. 213-
1 p.
|
article
|
| 11 |
Native herpes simplex virus glycoprotein D vaccine: immunogenicity and protection in animal models
|
Mishkin, E.M.
|
|
1991
|
9 |
3 |
p. 147-153
7 p.
|
article
|
| 12 |
New aromatic-dependent, non-reverting, avirulent Salmonella strains; useful for producing antibody and inducing salmonellosis immunity; vaccine
|
|
|
1991
|
9 |
3 |
p. 214-
1 p.
|
article
|
| 13 |
Potential subunit vaccine against Mycoplasma pulmonis purified by a protective monoclonal antibody
|
Lai, Wayne C.
|
|
1991
|
9 |
3 |
p. 177-184
8 p.
|
article
|
| 14 |
Predicting the adsorption of proteins by aluminium-containing adjuvants
|
Seeber, Sally J.
|
|
1991
|
9 |
3 |
p. 201-203
3 p.
|
article
|
| 15 |
Production of antibody against a disease pathogen; monoclonal antibody production against e.g. Taenia hydatigena, Haemonchus contortus, Fasciola hepatica, Corynebacterium pseudotuberculosis; hybridoma; potential vaccine
|
|
|
1991
|
9 |
3 |
p. 214-
1 p.
|
article
|
| 16 |
Promoter DNA derived from avipoxvirus, and chimeric gene: potential application in e.g. Newcastle-disease virus recombinant vaccine construction; gene cloning and expression; DNA sequence
|
|
|
1991
|
9 |
3 |
p. 214-
1 p.
|
article
|
| 17 |
Protection against European isolates of tick-borne encephalitis virus after vaccination with a new tick-borne encephalitis vaccine
|
Klockmann, U.
|
|
1991
|
9 |
3 |
p. 210-212
3 p.
|
article
|
| 18 |
Recombinant vaccinia virus expression of the bovine leukaemia virus envelope gene and protection of immunized sheep against infection
|
Portetelle, Daniel
|
|
1991
|
9 |
3 |
p. 194-200
7 p.
|
article
|
| 19 |
Secondary in vitro B lymphocyte (antibody) response to microbial antigens: use in appraisal of vaccine immunogenicity and cytokine immunoregulation
|
Bielefeldt Ohmann, H.
|
|
1991
|
9 |
3 |
p. 170-176
7 p.
|
article
|
| 20 |
Treating or preventing AIDS, AIDS-related complex, SIV virus infection or HIV virus infection; recombinant soluble T4 antigen protein production; recombinant vaccine construction
|
|
|
1991
|
9 |
3 |
p. 213-
1 p.
|
article
|
| 21 |
Use of protamine sulphate for elimination of substrate DNA in poliovaccines produced on continuous cell lines
|
Amosenko, F.A.
|
|
1991
|
9 |
3 |
p. 207-209
3 p.
|
article
|
| 22 |
Vaccine against liver fluke infection in ruminant, especially sheep; comprises glutathione-S-transferase extracted from adult Fasciola hepatica; DNA sequence
|
|
|
1991
|
9 |
3 |
p. 213-
1 p.
|
article
|
| 23 |
Vaccine against meningococcal infections; containing outer membrane proteins or fragments of Neisseria meningitidis; protein sequence
|
|
|
1991
|
9 |
3 |
p. 214-
1 p.
|
article
|
| 24 |
Vitamin E adjuvant formulations in mice
|
Tengerdy, R.P.
|
|
1991
|
9 |
3 |
p. 204-206
3 p.
|
article
|
Journal description